Skip to main content
. 2019 Mar 18;2019:9864841. doi: 10.1155/2019/9864841

Figure 5.

Figure 5

100-permutation test of PLS-DA model of therapeutic dose groups (A vs. B vs. C1 vs. C2) in ESI+ and ESI−.